Abstract
It is widely accepted that circadian rhythm disruption caused short- or long-term adverse effects on health. Although many previous studies have focused on exploration of the molecular mechanisms, there is no rapid, convenient, and non-invasive method to reveal the influence on health after circadian rhythm disruption. Here, we performed a high-resolution mass spectrometry-based data-independent acquisition (DIA) quantitative urinary proteomic approach in order to explore whether urine could reveal stress changes to those brought about by circadian rhythm disruption after sleep deprivation. After sleep deprivation, the subjects showed a significant increase in both systolic and diastolic blood pressure compared with routine sleep. More than 2000 proteins were quantified and they contained specific proteins for various organs throughout the body. And a total of 177 significantly up-regulated proteins and 68 significantly down-regulated proteins were obtained after sleep deprivation. These differentially expressed proteins (DEPs) were associated with multiple organs and pathways, which reflected widespread influences of sleep deprivation. Besides, machine learning identified a panel of five DEPs (CD300A, SCAMP3, TXN2, EFEMP1, and MYH11) that can effectively discriminate circadian rhythm disruption. Taken together, our results validate the value of urinary proteome in predicting and diagnosing the changes by circadian rhythm disruption.
Similar content being viewed by others
Data Availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the iProX [69] partner repository with the dataset identifier PXD038035.
References
Bass, J., & Takahashi, J. S. (2010). Circadian integration of metabolism and energetics. Science, 330(6009), 1349–1354.
Allada, R., & Bass, J. (2021). Circadian mechanisms in medicine. New England Journal of Medicine, 384(6), 550–561.
Bass, J., & Lazar, M. A. (2016). Circadian time signatures of fitness and disease. Science, 354(6315), 994–999.
Morris, C. J., et al. (2016). Circadian misalignment increases cardiovascular disease risk factors in humans. Proceedings of the National Academy of Sciences U S A, 113(10), E1402–E1411.
Zhao, Y., et al. (2022). Disruption of circadian rhythms by shift work exacerbates reperfusion injury in myocardial infarction. Journal of the American College of Cardiology, 79(21), 2097–2115.
Chellappa, S. L., et al. (2019). Impact of circadian disruption on cardiovascular function and disease. Trends in Endocrinology and Metabolism, 30(10), 767–779.
Thosar, S. S., Butler, M. P., & Shea, S. A. (2018). Role of the circadian system in cardiovascular disease. The Journal of Clinical Investigation, 128(6), 2157–2167.
Leng, Y., et al. (2019). Association between circadian rhythms and neurodegenerative diseases. Lancet Neurology, 18(3), 307–318.
Wu, H., et al. (2019). The role of sleep deprivation and circadian rhythm disruption as risk factors of Alzheimer’s disease. Frontiers in Neuroendocrinology, 54, 100764.
Kettner, N. M., et al. (2016). Circadian homeostasis of liver metabolism suppresses hepatocarcinogenesis. Cancer Cell, 30(6), 909–924.
Pan, A., et al. (2011). Rotating night shift work and risk of type 2 diabetes: Two prospective cohort studies in women. PLoS Medicine, 8(12), e1001141.
Hansen, J. (2017). Night shift work and risk of breast cancer. Current Environmental Health Reports, 4(3), 325–339.
Medic, G., Wille, M., & Hemels, M. (2017). Short- and long-term health consequences of sleep disruption. 9, 151–161.
Hastings, M. H. (1997). Central clocking. Trends in Neurosciences, 20(10), 459–464.
Inouye, S. I. T., & Kawamura, H. (1982). Characteristics of a circadian pacemaker in the suprachiasmatic nucleus. Journal of Comparative Physiology, 146(2), 153–160.
Ralph, M. R., et al. (1990). Transplanted suprachiasmatic nucleus determines circadian period. Science, 247(4945), 975–978.
Ruan, W., Yuan, X., & Eltzschig, H. K. (2021). Circadian rhythm as a therapeutic target. Nature Reviews Drug Discovery, 20(4), 287–307.
Hardin, P. E., Hall, J. C., & Rosbash, M. (1990). Feedback of the Drosophila period gene product on circadian cycling of its messenger RNA levels. Nature, 343(6258), 536–540.
Partch, C. L., Green, C. B., & Takahashi, J. S. (2014). Molecular architecture of the mammalian circadian clock. Trends in Cell Biology, 24(2), 90–99.
Hughes, S., et al. (2015). Photic regulation of clock systems. Methods in Enzymology, 552, 125–143.
Gekakis, N., et al. (1998). Role of the CLOCK protein in the mammalian circadian mechanism. Science, 280(5369), 1564–1569.
Richardson, G. S. (2005). The human circadian system in normal and disordered sleep. The Journal of Clinical Psychiatry, 66(Suppl 9), 3.
Hudson, A. N., Van Dongen, H. P. A., & Honn, K. A. (2020). Sleep deprivation, vigilant attention, and brain function: a review. Neuropsychopharmacology (New York, N.Y.), 45(1), 21–30.
Nakata, A. (2011). Effects of long work hours and poor sleep characteristics on workplace injury among full-time male employees of small- and medium-scale businesses. Journal of Sleep Research, 20(4), 576–584.
Bhadra, U., et al. (2017). Evolution of circadian rhythms: From bacteria to human. Sleep Medicine, 35, 49–61.
Matenchuk, B. A., Mandhane, P. J., & Kozyrskyj, A. L. (2020). Sleep, circadian rhythm, and gut microbiota. Sleep Medicine Reviews, 53, 101340.
Liu, H., & Chen, A. (2019). Roles of sleep deprivation in cardiovascular dysfunctions. Life Sciences, 219, 231–237.
Moreno-Villanueva, M., et al. (2018). The degree of radiation-induced DNA strand breaks is altered by acute sleep deprivation and psychological stress and is associated with cognitive performance in humans. Sleep, 41(7).
Bader, J. M., et al. (2020). Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer’s disease. Molecular Systems Biology, 16(6), e9356.
Wu, J., et al. (2021). Proteomics applications in biomarker discovery and pathogenesis for abdominal aortic aneurysm. Expert Review of Proteomics, 18(4), 305–314.
Risha, Y., et al. (2020). The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers. Science and Reports, 10(1), 13572.
Zhao, M., et al. (2017). A comprehensive analysis and annotation of human normal urinary proteome. Science and Reports, 7(1), 3024.
Gao, Y. (2013). Urine-an untapped goldmine for biomarker discovery? Science China Life Sciences, 56(12), 1145–1146.
Virreira, W. S., et al. (2021). Urinary proteome profiling for stratifying patients with familial Parkinson’s disease. EMBO Molecular Medicine, 13(3), e13257.
Ferrari, E., et al. (2019). Urinary proteomics profiles are useful for detection of cancer biomarkers and changes induced by therapeutic procedures. Molecules, 24(4), 794.
Duangkumpha, K., et al. (2019). Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis. PLoS One, 14(8), e0221024.
Depner, C. M., et al. (2018). Mistimed food intake and sleep alters 24-hour time-of-day patterns of the human plasma proteome. Proceedings of the National Academy of Sciences, 115(23).
Liu, T., et al. (2022). B serum proteome profiles revealed dysregulated proteins and mechanisms associated with insomnia patients: a preliminary study. Frontiers in Integrative Neuroscience, 16.
Geyer, P. E., et al. (2019). Plasma proteome profiling to detect and avoid sample-related biases in biomarker studies. EMBO Molecular Medicine, 11(11), e10427.
Adachi, J., et al. (2006). The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biology, 7(9), R80.
Geyer, P. E., et al. (2016). Plasma proteome profiling to assess human health and disease. Cell Systems, 2(3), 185–195.
Wang, D., et al. (2019). A deep proteome and transcriptome abundance atlas of 29 healthy human tissues. Molecular Systems Biology, 15(2), e8503.
Uhlen, M., et al. (2015). Proteomics. Tissue-based map of the human proteome. Science, 347(6220), 1260419.
Cao, R., et al. (2015). Light-regulated translational control of circadian behavior by eIF4E phosphorylation. Nature Neuroscience, 18(6), 855–862.
D’Abronzo, L. S., & Ghosh, P. M. (2018). eIF4E phosphorylation in prostate cancer. Neoplasia, 20(6), 563–573.
Knight, J. R. P., et al. (2021). MNK inhibition sensitizes KRAS-mutant colorectal cancer to mTORC1 inhibition by reducing eIF4E phosphorylation and c-MYC expression. Cancer Discovery, 11(5), 1228–1247.
Gong, C., et al. (2020). Phosphorylation independent eIF4E translational reprogramming of selective mRNAs determines tamoxifen resistance in breast cancer. Oncogene, 39(15), 3206–3217.
Piserà, A., Campo, A., & Campo, S. (2018). Structure and functions of the translation initiation factor eIF4E and its role in cancer development and treatment. Journal of Genetics and Genomics, 45(1), 13–24.
Guo, Q., et al. (2021). The MNK1/2–eIF4E axis supports immune suppression and metastasis in postpartum breast cancer. Cancer Research, 81(14), 3876–3889.
Peek, C. B., et al. (2017). Circadian clock interaction with HIF1α mediates oxygenic metabolism and anaerobic glycolysis in skeletal muscle. Cell Metabolism, 25(1), 86–92.
Deng, W., et al. (2018). The circadian clock controls immune checkpoint pathway in sepsis. Cell Reports, 24(2), 366–378.
Yuan, P., et al. (2020). Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells. Cancer Letters, 469, 498–509.
Yu, M., et al. (2018). Circadian regulator NR1D2 regulates glioblastoma cell proliferation and motility. Oncogene, 37(35), 4838–4853.
Jiang, L., et al. (2020). A quantitative proteome map of the human body. Cell, 183(1), 269-283.e19.
Edfors, F., et al. (2016). Gene-specific correlation of RNA and protein levels in human cells and tissues. Molecular Systems Biology, 12(10), 883.
Qin, W., et al. (2022). Proteome analysis of urinary biomarkers in a cigarette smoke-induced COPD rat model. Respiratory Research, 23(1), 156.
Cao, Y., et al. (2021). CD300a and CD300f molecules regulate the function of leukocytes. International Immunopharmacology, 93, 107373.
Lu, J. Y., et al. (2021). Secretory carrier membrane protein 3 interacts with 3A viral protein of enterovirus and participates in viral replication. Microbiology Spectrum, 9(1), e0047521.
Li, H., et al. (2017). Thioredoxin 2 offers protection against mitochondrial oxidative stress in H9c2 cells and against myocardial hypertrophy induced by hyperglycemia. International Journal of Molecular Sciences, 18(9), 1958.
Holzerova, E., et al. (2016). Human thioredoxin 2 deficiency impairs mitochondrial redox homeostasis and causes early-onset neurodegeneration. Brain, 139(2), 346–354.
Han, A. L., et al. (2017). Fibulin-3 promotes muscle-invasive bladder cancer. Oncogene, 36(37), 5243–5251.
Kim, I. G., et al. (2014). Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling. Oncogene, 33(30), 3908–3917.
Blue, E. E., et al. (2021). Non-coding variants inMYH11, FZD3, andSORCS3 are associated with dementia in women. Alzheimer’s & Dementia, 17(2), 215–225.
Barwinska, D., et al. (2021). Molecular characterization of the human kidney interstitium in health and disease. Science Advances, 7(7).
Shen, B., et al. (2020). Proteomic and metabolomic characterization of COVID-19 patient sera. Cell, 182(1), 59-72 e15.
Shao, C., et al. (2019). Comprehensive analysis of individual variation in the urinary proteome revealed significant gender differences. Molecular and Cellular Proteomics, 18(6), 1110–1122.
Bailey, M., & Silver, R. (2014). Sex differences in circadian timing systems: Implications for disease. Frontiers in Neuroendocrinology, 35(1), 111–139.
Tian, W., et al. (2020). Immune suppression in the early stage of COVID-19 disease. Nature Communications, 11(1).
Ma, J., et al. (2019). iProX: An integrated proteome resource. Nucleic Acids Research, 47(D1), D1211–D1217.
Funding
This study was supported by the National Natural Science Foundation (32171431).
Author information
Authors and Affiliations
Contributions
Conceptualization: LX. Methodology: XL, LM, and QF. Formal analysis: LZ, LX, and SM. Investigation: XL, ZH, YW, and LZ. Data curation: LZ, XW, LX, and SM. Writing—original draft preparation: LZ and SM. Writing—review and editing: LX, XW, and SM. Funding acquisition: LX and XL.
Corresponding authors
Ethics declarations
Ethics Approval
This study had been approved by the ethics committee of Shanghai Jiao Tong University School of Medicine with No. 2022-A-05.
Consent to Participate
All participants volunteered to participate in this study, and informed consent had been obtained from them.
Consent for Publication
All authors agree to publish their work.
Conflicts of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhou, L., Lu, X., Wang, X. et al. A Pilot Urinary Proteome Study Reveals Widespread Influences of Circadian Rhythm Disruption by Sleep Deprivation. Appl Biochem Biotechnol 196, 1992–2011 (2024). https://doi.org/10.1007/s12010-023-04666-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-023-04666-9